Location matters - Genotype-phenotype correlation in LRSAM1 mutations associated with rare Charcot-Marie-Tooth neuropathy CMT2P.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
02 2021
Historique:
received: 24 07 2020
revised: 16 11 2020
accepted: 23 11 2020
pubmed: 9 1 2021
medline: 16 11 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

More than 80 genes are known to be associated with Charcot-Marie-Tooth disease (CMT). Mutations of LRSAM1 were identified as a rare cause and define the subgroup of axonal neuropathy CMT2P. We identified additional 14 patients out of 12 families. Clinical and electrophysiological data confirm a late-onset axonal neuropathy with a predominance of sensorimotor impairment. The patients harbored ten different variants in LRSAM1, seven of which were novel. Due to variable inheritance patterns and clustering of pathogenic variants in 3´-prime exons, interpretation of genetic variants in LRSAM1 is challenging. The majority follows dominant inheritance, whereas recessive inheritance has been described for one variant. Variants at the 3`end may or may not escape from nonsense-mediated decay, thereby defining the pattern of inheritance. Our data emphasize the importance of the C-terminal RING domain, which exerts a dominant-negative effect on protein function, whenever affected by an altered or truncated protein. In conclusion, CMT2P is a rare, but nevertheless relevant cause of adult-onset axonal and painful neuropathy. ACMG (American College of Medical Genetics and genomics) criteria should be carefully applied in variant interpretation, with special attention to premature termination codon-introducing variants and their location within the gene.

Identifiants

pubmed: 33414056
pii: S0960-8966(20)30676-3
doi: 10.1016/j.nmd.2020.11.011
pii:
doi:

Substances chimiques

LRSAM1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-133

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Peter Reilich (P)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University Munich, Munich, Germany.

Beate Schlotter (B)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University Munich, Munich, Germany.

Federica Montagnese (F)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University Munich, Munich, Germany.

Berit Jordan (B)

Department of Neurology, University Hospital of Halle, Halle, Germany; Department of Neurology, University Hospital of Heidelberg, Heidelberg, Germany.

Friedrich Stock (F)

Institute of Human Genetics, Universitätsklinikum Münster, Münster, Germany.

Mario Schäff-Vogelsang (M)

Klinik für Neurologie, Diakonie-Krankenhaus, Schwäbisch Hall, Germany.

Benjamin Hotter (B)

Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt- Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Katherina Eger (K)

Gemeinschaftspraxis für Neurologie und Psychiatrie, Leipzig, Germany.

Isabel Diebold (I)

Department of Pediatrics, Technical University of Munich School of Medicine, Munich, Germany; Medical Genetics Centre, Bayerstr. 3-5, 80335 Munich, Germany.

Hannes Erdmann (H)

Medical Genetics Centre, Bayerstr. 3-5, 80335 Munich, Germany.

Kerstin Becker (K)

Medical Genetics Centre, Bayerstr. 3-5, 80335 Munich, Germany.

Ulrike Schön (U)

Medical Genetics Centre, Bayerstr. 3-5, 80335 Munich, Germany.

Angela Abicht (A)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University Munich, Munich, Germany; Medical Genetics Centre, Bayerstr. 3-5, 80335 Munich, Germany. Electronic address: angela.abicht@mgz-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH